In recent years, there has been an increase in the number of registered clinical trials evaluating recombinant adeno-associated virus (AAV)-based gene therapies, in part due to AAV’s ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback